Six-Feet Deep: Advancing Therapies for Spectrum of Choroidal Disease

Scroll to the Bottom of this Information to Begin this Course

This activity is jointly provided by Global Education Group and iVista Medical Education, Inc.

This activity is supported by an independent medical education grant from Bayer Inc. Regeneron Pharmaceuticals, Inc.

Credit Available

• Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

The educational design of this activity addresses the needs of practicing retina specialists, retinal fellows in training, and vitreoretinal surgeons, comprehensive ophthalmologists, and ophthalmic techs involved in the treatment of patients with choroidal disease.

Statement of Need/Program Overview

The Ocular Imaging 360 webcast series is aimed at retina specialists around the world on the ever-evolving field of retinal imaging. Each webcast is designed to provide an in-depth dynamic case-based presentation of common and rare disease states, interpreted through multi-modal retinal imaging.

Learning Objectives

After completing this activity, the participant should be better able to:

• Describe how to optimize utilization of anti-VEGF for CNVM in pachychoroid disease
• Recognize the spectrum of pachychoroid disease
• Identify the utility of swept-source OCT in examining the choroidal vasculature
• Recognize the role of OCT angiography in choroidal disease management

 

Faculty

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and iVista Medical Education, Inc. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Term of Offering

This activity was released on November 16, 2020 and is valid for one year. Requests for credit must be made no later than November 16, 2021.

Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must attend read the CME information, watch the webcast video, score 70% or better on the posttest, and complete the program evaluation.

Fee Information& Refund/Cancellation Policy

There is no fee for this educational activity.

System Requirements

Recommended to use Google Chrome or Microsoft Firefox as the browser.

Disclosures of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Netan Choudhry, MD FRCS(C) DABO

• Consultant/Independent Contractor: Optos PLC, Allergan, Johnson & Johnson, Topcon, Bayer, Carl Zeiss, Novartis
• Grant/Research Support: Optos PLC, Topcon, Bayer
• Honoraria: Optos PLC, Allergan, Johnson & Johnson, Topcon, Bayer, Carl Zeiss, Novartis
• Speaker's Bureau: Optos PLC, Allergan, Johnson & Johnson, Topcon, Bayer, Carl Zeiss, Novartis
• Advisory Board: Topcon, Optos PLC, Bayer, Novartis

 

K. Bailey Freund, MD

• Consultant/Independent Contractor: Genentech, Zeiss, Allergan, Novartis, Bayer, and Heidelberg Engineering
• Grant/Research Support: Genentech/Roche

 

Marion Munk, MD, PhD

• Advisory Board: Bayer, Novartis, Zeiss Meditech, RetinAI, Lumithera, Isarna Therapeutics, Gensight Therapeutics

 

Francesco Pichi, MD

• Consultant/Independent Contractor: Zeiss, AbbVie, Bayer
• Grant/Research Support: Zeiss, AbbVie
• Honoraria: Novartis, Allergan

 

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: Lindsay Borvansky, Andrea Funk, Liddy Knight, Ashley Cann, Yaremi Koopot, and Alana Ochoa all have reported that they do not have any relevant financial relationships to disclose.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

1. Read the CME/CE information and faculty disclosures.
2. Participate in the online activity.
3. Submit the evaluation form.

Certificates will be emailed to the participant

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and iVista Medical Education, Inc. do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.